BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16870106)

  • 1. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
    Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
    Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
    Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.
    Gitiaux C; De Antonio M; Aouizerate J; Gherardi RK; Guilbert T; Barnerias C; Bodemer C; Brochard-Payet K; Quartier P; Musset L; Chazaud B; Desguerre I; Bader-Meunier B
    Rheumatology (Oxford); 2016 Mar; 55(3):470-9. PubMed ID: 26424834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
    Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
    Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients.
    Miles L; Bove KE; Lovell D; Wargula JC; Bukulmez H; Shao M; Salisbury S; Bean JA
    Arthritis Rheum; 2007 Oct; 57(7):1183-91. PubMed ID: 17907236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis.
    Sallum AM; Marie SK; Wakamatsu A; Sachetti S; Vianna MA; Silva CA; Kiss MH
    J Rheumatol; 2004 Apr; 31(4):801-7. PubMed ID: 15088312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis.
    Gonçalves FG; Chimelli L; Sallum AM; Marie SK; Kiss MH; Ferriani VP
    J Rheumatol; 2002 Jun; 29(6):1301-7. PubMed ID: 12064850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of magnetic resonance imaging in the diagnosis of juvenile dermato-myositis and polymyositis in Chinese children].
    Lai JM; Wu FQ; Zhou ZX; Yuan XY; Su GX; Li SN; Yan YC; Zhu J; Kang M
    Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):767-772. PubMed ID: 27784480
    [No Abstract]   [Full Text] [Related]  

  • 9. Pattern of myogenesis and vascular repair in early and advanced lesions of juvenile dermatomyositis.
    Baumann M; Gumpold C; Mueller-Felber W; Schoser B; Haberler C; Loescher WN; Rostásy K; Fischer MB; Wanschitz JV
    Neuromuscul Disord; 2018 Dec; 28(12):973-985. PubMed ID: 30389421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile dermatomyositis: a tertiary center experience.
    Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
    Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and disease course of patients with juvenile dermatomyositis.
    Gowdie PJ; Allen RC; Kornberg AJ; Akikusa JD
    Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.
    Smith RL; Sundberg J; Shamiyah E; Dyer A; Pachman LM
    J Rheumatol; 2004 Aug; 31(8):1644-9. PubMed ID: 15290747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases.
    Braczynski AK; Harter PN; Zeiner PS; Drott U; Tews DS; Preusse C; Penski C; Dunst M; Weis J; Stenzel W; Mittelbronn M
    Neuromuscul Disord; 2016; 26(4-5):283-91. PubMed ID: 27020463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
    Moneta GM; Pires Marafon D; Marasco E; Rosina S; Verardo M; Fiorillo C; Minetti C; Bracci-Laudiero L; Ravelli A; De Benedetti F; Nicolai R
    Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
    Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I
    Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical and muscular pathological study of dermatomyositis with perifascicular atrophy changes].
    Liu Z; Chen L; Guo YP; Ren HT; Zhao YH
    Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):698-701. PubMed ID: 23158920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
    Grundtman C; Tham E; Ulfgren AK; Lundberg IE
    Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body magnetic resonance imaging in the assessment of muscular involvement in juvenile dermatomyositis/polymyositis patients.
    Castro TC; Lederman H; Terreri MT; Caldana WI; Zanoteli E; Hilário MO
    Scand J Rheumatol; 2014; 43(4):329-33. PubMed ID: 25087579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases.
    Sato JO; Sallum AM; Ferriani VP; Marini R; Sacchetti SB; Okuda EM; Carvalho JF; Pereira RM; Len CA; Terreri MT; Lotufo SA; Romanelli PR; Ramos VC; Hilario MO; Silva CA; Corrente JE; Saad-Magalhães C;
    Clin Exp Rheumatol; 2009; 27(6):1031-8. PubMed ID: 20149327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.
    Gitiaux C; Latroche C; Weiss-Gayet M; Rodero MP; Duffy D; Bader-Meunier B; Glorion C; Nusbaum P; Bodemer C; Mouchiroud G; Chelly J; Germain S; Desguerre I; Chazaud B
    Arthritis Rheumatol; 2018 Jan; 70(1):134-145. PubMed ID: 28941175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.